Robert Ellis

Robert Ellis is a seasoned executive with extensive experience in the fields of biotechnology and electrofluidics. Currently serving as President at Strategic- intent.com since January 2010, Robert also holds the positions of CEO and Chairman at Mendo portable electrofluidics since 2018, where innovative portable liquid-handling technology is developed. Additionally, Robert has been the CEO of Mendo Electro fluidics since March 2018, a Technical Consultant at Propel(x) since June 2016, and a consultant for Metabolon since July 2012. As the CEO of Tissuentix since March 2012, and a Board Member at Perfinity Biosystems since July 2011, Robert contributes significantly to multiple organizations. Further involvement includes advisory roles at Fletcher Spaght, Inc. since 2008 and a directorial position at SciGene since April 2005. Robert's prior leadership at Perfinity Biosciences spanned from April 2013 to November 2014. Educational qualifications include degrees in Chemistry from Hartwick College and Rensselaer Polytechnic Institute, along with studies in business at UCLA's Claremont Business School under Peter Drucker.